Acquisition play Recent majority stake acquisition by San Francisco Equity Partners signals a growth-phase trajectory and potential for expanded contract manufacturing partnerships in consumer value chains, creating opportunities to engage Formula Corp on scalable projects and new product lines.

Private equity interest Private equity ownership often seeks operational improvements and capacity expansion; align outreach around enhanced formulations, scale-up capabilities, and optimized supply chain services to capture expansion opportunities.

Contract manufacturing focus Formula Corp specializes in custom compounder and contract packing for personal care, industrial, and institutional chemicals, presenting a clear path to upsell broader formulation development, packaging optimization, and regulatory-compliant manufacturing services.

Mid-market potential With 11-50 employees and revenue in the mid tens of millions, there is a weathered, mid-market footprint ideal for scalable specialty chemical solutions, process improvements, and third-party logistics enhancements.

Technology levers The tech stack indicates modern web and e-commerce capabilities; leverage digital sourcing, product data management, and streamlined RFP processes to reduce time-to-contract and accelerate pilot production opportunities.